Pluristem Heads for Two-Month High on $3.2 Million Israeli Grant
This article is for subscribers only.
Pluristem Therapeutics Inc. headed for the highest close in more than two months after the developer of cell-therapy products said it received a grant of
11.8 million shekels ($3.2 million) from the Israeli government.